Sun Pharmaceutical Industries Limited: all 327 studies

Page 1 of 4. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the FaceRecruitingNCT07729579Phase 1
• Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia AreataRecruitingNCT07617597Phase 3
• Study to Evaluate if Exposure to Drug is Impacted in Participants With Renal InsufficiencyRecruitingNCT07385547Phase 1
• Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes MellitusRecruitingNCT07282743Phase 2
• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper ExtremitiesRecruitingNCT07144852Phase 3
• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and ScalpRecruitingNCT07144345Phase 3
• Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia AreataRecruitingNCT07133308Phase 3
• A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.RecruitingNCT07042100Phase 1
• Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.RecruitingNCT05422911Phase 2
• Safety Study for Prospective Assessment of Pregnancy Outcomes in Patients Treated With TildrakizumabRecruitingNCT03992729
• A Study Evaluating the Efficacy and Safety of Clascoterone Cream 1% in Skin of Color Patients With AcneCompletedNCT06415305Phase 4Results posted
• A Study to Evaluate the Impact of Clascoterone 1% Cream on Skin Barrier Properties in Acne Prone PatientsCompletedNCT06415292Phase 4Results posted
• A Study to Evaluate the Reduction in Sebum (Skin Oil) Induced by Clascoterone Cream 1% in Acne PatientsCompletedNCT06415279Phase 4Results posted
• A Study Assessing the Efficacy and Safety of Combined Use of Clascoterone 1% Cream and Duac Gel (Benzoyl Peroxide/Clindamycin) for the Treatment of AcneCompletedNCT06336629Phase 4Results posted
• A Study Assessing the Efficacy of Combined Use of Clascoterone 1% Cream and Adapalene 0.3% for the Treatment of AcneCompletedNCT06336603Phase 4Results posted
• European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia AreataCompletedNCT05041803Phase 3Results posted
• A Therapeutic Equivalence Study in Subjects With Primary Open Angle Glaucoma or Ocular HypertensionCompletedNCT05022004Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)CompletedNCT04797650Phase 3Results posted
• Study of Pemetrexed+Platinum Chemotherapy With or Without Cosibelimab in First Line Metastatic Non-squamous NSCLCTerminatedNCT04786964Phase 3Results posted
• A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia AreataCompletedNCT04784533Phase 2Results posted
• To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic DermatitisCompletedNCT04684485Phase 2Results posted
• To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque PsoriasisCompletedNCT04566666Phase 2Results posted
• Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)CompletedNCT04518995Phase 3Results posted
• Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee OsteoarthritisCompletedNCT04506463Phase 2Results posted
• Effect of Cequa™ in Subjects With Dry Eye DiseaseCompletedNCT04357795Phase 4Results posted
• A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-692 as an Adjunctive Treatment in Adults With SchizophreniaCompletedNCT04158687Phase 2Results posted
• Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia AreataCompletedNCT03941548Phase 2Results posted
• Efficacy and Safety of Tildrakizumab in the Treatment of Scalp PsoriasisCompletedNCT03897088Phase 3Results posted
• Efficacy and Safety Study of Tildrakizumab in the Treatment of Nail PsoriasisCompletedNCT03897075Phase 3Results posted
• Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia AreataCompletedNCT03811912Phase 2Results posted
• A Real World Study Evaluating the Long-Term Quality of Life of Tildrakizumab in Adult Patients With PsoriasisCompletedNCT03718299Phase 4Results posted
• PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706TerminatedNCT03655236Phase 2Results posted
• Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.CompletedNCT03552276Phase 2/3Results posted
• A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)CompletedNCT03528577Phase 3Results posted
• Evaluation of Safety and Efficacy of PDP-716CompletedNCT03450629Phase 3Results posted
• Evaluation of Efficacy and Safety of SDN-037CompletedNCT03426267Phase 3Results posted
• Evaluation of Adrenal Suppression Potential and Pharmacokinetics of Halobetasol Lotion 0.05%TerminatedNCT03212963Phase 4Results posted
• 2nd Study to Assess ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract SurgeryCompletedNCT03192150Phase 3Results posted
• Study to Evaluate ISV-305 Compared to Vehicle for Treatment of Inflammation and Pain Associated With Cataract SurgeryCompletedNCT03192137Phase 3Results posted
• Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia AreataCompletedNCT03137381Phase 2Results posted
• Efficacy and Safety Study of SUNPG1622TerminatedNCT02980705Phase 2Results posted
• Efficacy and Safety Study of SUNPG1623CompletedNCT02980692Phase 2Results posted
• One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™CompletedNCT02962284Phase 2Results posted
• Efficacy Study in Patients With Acne Vulgaris.CompletedNCT02935036Phase 2Results posted
• Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical StudyCompletedNCT02933879Phase 2Results posted
• Phase III Clinical Study in Patients With Mild to Severe Scalp PsoriasisCompletedNCT02933866Phase 3Results posted
• Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXSCompletedNCT02933528Phase 2Results posted
• Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical ProductCompletedNCT02933502Phase 2Results posted
• An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.CompletedNCT02932891Phase 2Results posted
• An Open Label, Safety Study to Assess the Potential for Adrenal SuppressionCompletedNCT02932878Phase 2Results posted
• Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp PsoriasisCompletedNCT02932462Phase 3Results posted
• An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis SiccaCompletedNCT02845674Phase 3Results posted
• A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT02737332Phase 2Results posted
• Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis SiccaCompletedNCT02688556Phase 3Results posted
• Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on FaceCompletedNCT02632110Phase 2Results posted
• Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML TherapiesTerminatedNCT02629692Phase 1/2Results posted
• Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)CompletedNCT02628236Phase 2Results posted
• Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque PsoriasisCompletedNCT02618759Phase 3Results posted
• Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque PsoriasisCompletedNCT02601469Phase 2Results posted
• Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic DermatitisCompletedNCT02595073Phase 3Results posted
• Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic DermatitisCompletedNCT02595008Phase 2Results posted
• To Evaluate The Efficacy And Safety Of Sunpharma1505 Compared With Reference1505 In Subjects With Active Rheumatoid ArthritisTerminatedNCT02534896Phase 3Results posted
• ABSORICA in Patients With Severe Recalcitrant Nodular AcneCompletedNCT02457520Phase 4Results posted
• A Randomized Double Blind Vehicle Controlled Dose Ranging Parallel Design Multiple Site Clinical StudyCompletedNCT02413229Phase 2Results posted
• Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe NailCompletedNCT02343627Phase 2Results posted
• Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque PsoriasisCompletedNCT02340169Phase 4Results posted
• Maximal Use Systemic Exposure (MUSE) Study of Levulan KerastickCompletedNCT02281136Phase 2Results posted
• Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis SiccaCompletedNCT02254265Phase 2/3Results posted
• Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic TherapyCompletedNCT02239679Phase 2Results posted
• Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper ExtremitiesCompletedNCT02137785Phase 3Results posted
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SPARC1316CompletedNCT02041221Phase 1/2Results posted
• Study of SPARC1103 in Subjects With SpasticityCompletedNCT02027025Phase 2Results posted
• Efficacy and Safety of SPARC1310 in Seasonal Allergic RhinitisCompletedNCT01940146Phase 2Results posted
• Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery SubjectsCompletedNCT01808547Phase 3Results posted
• Safety Study of SPARC1104CompletedNCT01797185Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous Tildrakizumab (SCH 900222/MK-3222) in Participants With Moderate-to-Severe Chronic Plaque Psoriasis Followed by a Long-term Extension Study (MK-3222-011)CompletedNCT01729754Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)CompletedNCT01722331Phase 3Results posted
• Pharmacokinetic and Pharmacodynamic Study of CyclofemCompletedNCT01699022Phase 1/2Results posted
• Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery SubjectsCompletedNCT01576952Phase 3Results posted
• Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis SubjectsCompletedNCT01543490Phase 3Results posted
• Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)CompletedNCT01475955Phase 2Results posted
• Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)CompletedNCT01458587Phase 2Results posted
• Efficacy and Safety of SPARC0921 in Subjects With SpasticityCompletedNCT01457352Phase 3Results posted
• Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes MellitusCompletedNCT01406717Phase 3Results posted
• Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract SurgeryCompletedNCT01387464Phase 2Results posted
• Effect of Different Concentrations of SPARC1102 on Allergic ConjunctivitisCompletedNCT01320553Phase 2Results posted
• Effects of Desoximetasone Spray 0.25% in Patients With Moderate to Severe Plaque PsoriasisCompletedNCT01206660Phase 3Results posted
• Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque PsoriasisCompletedNCT01206387Phase 3Results posted
• Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery VolunteersCompletedNCT01190878Phase 1/2Results posted
• Desoximetasone Spray 0.25%, Hypothalamic Pituitary Adrenal (HPA) Axis StudyCompletedNCT01043393Phase 2Results posted
• Desoximetasone Spray 0.05%, 0.25%; Dose Ranging StudyCompletedNCT01018134Phase 2Results posted
• Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head LiceCompletedNCT00963508Phase 3Results posted
• Efficacy and Safety of SPARC0912 and Reference0912 in Open Angle Glaucoma or Ocular HypertensionCompletedNCT00947661Phase 3Results posted
• Evaluation of Safety of SPARC0913 in Open Angle Glaucoma or Ocular HypertensionCompletedNCT00945958Phase 3Results posted
• Efficacy, Safety and Tolerability of a Novel Malathion Formulation in Patients 2 Years and Older With Head LiceCompletedNCT00927472Phase 3Results posted
• Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea PedisCompletedNCT00835510Phase 1Results posted
• Bioequivalence Study of Two Imiquimod Cream 5%CompletedNCT00828568Phase 1Results posted
• Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head LiceCompletedNCT00752973Phase 2/3Results posted
• Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial AcneCompletedNCT00706433Phase 2Results posted
• A Study Comparing Ivermectin Cream 1%, Soolantra™ Cream 1%, PrROSIVER® Cream1% to Placebo Control in the Treatment of Moderate to Severe Facial Rosacea.CompletedNCT07795567Phase 1

← Sun Pharmaceutical Industries Limited overview and focus areas